Structure–function associations in hippocampus in bipolar disorder

https://doi.org/10.1016/j.biopsycho.2012.01.008Get rights and content

Abstract

Hippocampus volume decreases and verbal memory deficits have been reported in bipolar disorder (BD) as independent observations. We investigated potential associations between these deficits in subjects with BD. Hippocampus volumes were measured on magnetic resonance images of 31 subjects with BD and 32 healthy comparison (HC) subjects. The California Verbal Learning Test-Second Edition (CVLT) assessed verbal memory function in these subjects. Compared to the HC group, the BD group showed both significantly smaller hippocampus volumes and impaired performance on CVLT tests of immediate, short delay and long delay cued and free recall. Further, smaller hippocampus volume correlated with impaired performance in BD. Post hoc analyses revealed a trend towards improved memory in BD subjects taking antidepressant medications. These results support associations between morphological changes in hippocampus structure in BD and verbal memory impairment. They provide preliminary evidence pharmacotherapy may reverse hippocampus-related memory deficits.

Highlights

California Verbal Learning Test (CVLT) performance is decreased in bipolar disorder. ► MRI showed hippocampus volumes are decreased in bipolar disorder. ► Hippocampus volume was associated with CVLT performance in bipolar disorder.

Introduction

Converging evidence implicates the hippocampus in bipolar disorder (BD). Findings from both postmortem histochemical studies and neuroimaging research demonstrate structural hippocampal abnormalities in BD, including decreased cell density, abnormal markers of neuronal function and plasticity, and decreases in hippocampus volume (Bearden et al., 2008, Chepenik et al., 2009, Frazier et al., 2005, Hauser et al., 1989, Noga et al., 2001, Savitz and Drevets, 2010, Strasser et al., 2005, Swayze et al., 1992). Medications used to treat BD are thought to function, at least in part, by stimulating neurogenesis and neuroprotection within hippocampus (Chen et al., 2000, Hao et al., 2004, Manji et al., 2000, Walz et al., 2008).

Consistent with these neurobiological findings, deficits in verbal memory functions that are subserved by the hippocampus are the cognitive abnormalities most consistently identified in individuals with BD (Robinson et al., 2006). These deficits are present across all mood states in BD including euthymia (Cavanagh et al., 2002, Clark et al., 2001, Deckersbach et al., 2004, Glahn et al., 2005, Martinez-Aran et al., 2004a, Martinez-Aran et al., 2004b, Matsuo et al., 2009, Pavuluri et al., 2006, van Gorp et al., 1999, Wolfe et al., 1987). They have been identified in both children and adults with BD (Cavanagh et al., 2002, Clark et al., 2001, Deckersbach et al., 2004, Glahn et al., 2005, Pavuluri et al., 2006, van Gorp et al., 1999, Wolfe et al., 1987) and in their unaffected siblings (Gourovitch et al., 1999, Keri et al., 2001, Kieseppa et al., 2005).

The California Verbal Learning Test (CVLT) is a widely used measure of declarative verbal memory functions, including episodic verbal learning and recall, shown to be associated with hippocampus functioning and disrupted in individuals with hippocampus pathology (Deweer et al., 1995, Kohler et al., 1998, Lepage et al., 1998, Libon et al., 1998, Tischler et al., 2006, Yucel et al., 2007). Although the CVLT also tests various other constructs, subjects with BD tend to demonstrate difficulty on the CVLT measures of immediate and delayed recall (Altshuler et al., 2004, Cavanagh et al., 2002, Glahn et al., 2005, Martinez-Aran et al., 2004a, Martinez-Aran et al., 2004b, Senturk et al., 2007, Simonsen et al., 2008, van Gorp et al., 1998). Together with the findings described above, these results suggest verbal memory dysfunction is a pervasive problem in BD and may reflect an underlying vulnerability in the disorder for hippocampus disturbances. However, no study has yet demonstrated a direct association between hippocampus volume and verbal memory dysfunction in BD.

The present study tested the hypotheses that BD individuals would demonstrate decreases in hippocampus volume, as well as decreased verbal memory functioning as measured by the CVLT, relative to healthy comparison (HC) subjects. It was further hypothesized there would be an association between the magnitude of hippocampus volume decreases and verbal memory decreases in subjects with BD.

Section snippets

Subjects

Subjects included 31 adults with BD (58% female, ages 20–58 years) and 32 HC individuals (68% female, ages 19–58 years). Study subjects were recruited through the Veterans Affairs Connecticut Health Care System (West Haven, CT), the Yale School of Medicine (New Haven, CT), clinicians in the community and from advertisement in local newspapers. All subjects provided written, informed consent for participation in this study protocol as approved by the Yale School of Medicine and Department of

Demographic variables

The groups did not significantly differ in age, education, sex distribution, pre-morbid or current IQ (Table 1).

CVLT assessment

AMNART was significantly associated with total immediate recall [F(1,59) = 4.9, p = 0.031]. Compared to the HC group, the group with BD demonstrated significantly impaired performance on total immediate recall, short delay cued and free recall and long delay cued recall (Table 2). The group with BD demonstrated a trend towards impaired performance on long delay free recall, relative to

Discussion

This study demonstrated a positive correlation between hippocampus volume and CVLT performance in individuals with BD. These findings bring together for the first time the separate observations that hippocampus size is reduced and its function is reduced in adults with BD, compared to healthy individuals. The presence of a correlation between these findings suggests morphological differences in hippocampus in BD may be associated with measurable verbal memory dysfunction.

The mechanisms that

Funding sources

Grant Sponsor: The Department of Veterans Affairs Research Enhancement Award Program; Grant Sponsor: The National Institute of Mental Health, Grant numbers: R01MH69747, R01MH070902, K01MH086621, UL1 T32MH14276; Grant Sponsor: National Institute of Health National Center for Research Resources, CTSA Grant Number: UL1 RR024139; Grant Sponsors: The National Alliance for Research on Schizophrenia and Depression, The Attias Family Foundation, Marcia Simon Kaplan, Women's Investigator Program – The

Acknowledgements

We thank Kathleen Colonese, Susan Quatrano, Philip Markovich and Allison McDonough for their work with the study participants and database management, Hedy Sarofin, Karen Martin, and Terry Hickey for their technical expertise, and the research subjects for their participation. We also thank Dr. Brenda Milner for her expert scientific consultation.

References (74)

  • H.K. Manji et al.

    Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness

    Biological Psychiatry

    (2000)
  • J.T. Noga et al.

    A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder

    Psychiatry Research

    (2001)
  • L.J. Robinson et al.

    A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder

    Journal of Affective Disorders

    (2006)
  • H.C. Strasser et al.

    Hippocampal and ventricular volumes in psychotic and nonpsychotic bipolar patients compared with schizophrenia patients and community control subjects: a pilot study

    Biological Psychiatry

    (2005)
  • V.W. Swayze et al.

    Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

    Biological Psychiatry

    (1992)
  • W.G. van Gorp et al.

    Declarative and procedural memory in bipolar disorder

    Biological Psychiatry

    (1999)
  • J.C. Walz et al.

    Effects of lithium and valproate on serum and hippocampal neurotrophin-3 levels in an animal model of mania

    Journal of Psychiatric Research

    (2008)
  • J. Wolfe et al.

    Verbal memory deficits associated with major affective disorders: a comparison of unipolar and bipolar patients

    Journal of Affective Disorders

    (1987)
  • M. Ystad et al.

    Subcortical functional connectivity and verbal episodic memory in healthy elderly – a resting state fMRI study

    NeuroImage

    (2010)
  • L. Albuquerque et al.

    Effect of lesion site on serial position during list learning: a study with the CVLT

    International Journal of Neuroscience

    (2008)
  • M. Atmaca et al.

    Hippocampal 1H MRS in patients with bipolar disorder taking valproate versus valproate plus quetiapine

    Psychological Medicine

    (2007)
  • J.V. Baldo et al.

    Memory performance on the California Verbal Learning Test-II: findings from patients with focal frontal lesions

    Journal of the International Neuropsychological Society

    (2002)
  • C.E. Bearden et al.

    Three-dimensional mapping of hippocampal anatomy in unmedicated and lithium-treated patients with bipolar disorder

    Neuropsychopharmacology

    (2008)
  • J.T. Cavanagh et al.

    Case–control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania

    British Journal of Psychiatry

    (2002)
  • G. Chen et al.

    Enhancement of hippocampal neurogenesis by lithium

    Journal of Neurochemistry

    (2000)
  • L.G. Chepenik et al.

    Effects of the brain-derived neurotrophic growth factor val66met variation on hippocampus morphology in bipolar disorder

    Neuropsychopharmacology

    (2009)
  • L. Clark et al.

    A neuropsychological investigation of prefrontal cortex involvement in acute mania

    American Journal of Psychiatry

    (2001)
  • B. Czeh et al.

    Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

    Proceedings of the National Academy of Sciences of the United States of America

    (2001)
  • T. Deckersbach et al.

    Episodic memory impairment in bipolar disorder and obsessive-compulsive disorder: the role of memory strategies

    Bipolar Disorders

    (2004)
  • D. Delis et al.

    California Verbal Learning Test-II

    (2000)
  • G. Di Stafano et al.

    Volume of focal brain lesions and hippocampal formation in relation to memory function after closed head injury in children

    Journal of Neurology, Neurosurgery and Psychiatry

    (2000)
  • M. Deuschle et al.

    Impaired declarative memory in depressed patients is slow to recover: clinical experience

    Pharmacopsychiatry

    (2004)
  • B. Deweer et al.

    Memory disorders in probable Alzheimer's disease: the role of hippocampal atrophy as shown with MRI

    Journal of Neurology, Neurosurgery & Psychiatry

    (1995)
  • D. Dowlatshahi et al.

    Increased hippocampal supragranular Timm staining in subjects with bipolar disorder

    Neuroreport

    (2000)
  • R.S. Duman et al.

    A molecular and cellular theory of depression

    Archives of General Psychiatry

    (1997)
  • R.W. Elwood

    The California Verbal Learning Test: psychometric characteristic and clinical application

    Neuropsychology Review

    (1995)
  • S.H. Fatemi et al.

    Altered levels of the synaptosomal associated protein SNAP-25 in hippocampus of subjects with mood disorders and schizophrenia

    Neuroreport

    (2001)
  • Cited by (39)

    • Resilience and young people's brain structure, function and connectivity: A systematic review

      2022, Neuroscience and Biobehavioral Reviews
      Citation Excerpt :

      The hippocampus is commonly associated with memory but forms part of the limbic system, and so is also implicated in emotion processing (Femenia et al., 2012). Due to its high number of glucocorticoid receptors, the hippocampus is impacted by chronic stress, and accordingly, reduced hippocampal volume has been associated with mood disorders such as major depressive disorder and bipolar disorder (Chepenik et al., 2012; Levone et al., 2015). However, although there is consistency across the adult and youth resilience literature with regards to associations between hippocampal volume and resilience, these findings should be treated with caution as it may be that resilience is not associated with greater hippocampal volume, but comparatively greater volume.

    • Doxycycline reverses cognitive impairment, neuroinflammation and oxidative imbalance induced by D-amphetamine mania model in mice: A promising drug repurposing for bipolar disorder treatment?

      2021, European Neuropsychopharmacology
      Citation Excerpt :

      Hence, we decided to evaluate additional molecular mechanisms for DOXY's protective effect in this brain area. Importantly, compelling evidence implicates the hippocampus as a critical area for BD neuropathology (Chepenik et al., 2012). Findings from both post-mortem and neuroimaging studies have shown hippocampal reduced volume, decreased cell density, decreased neuronal plasticity, and altered glial reactivity in BD patients (Savitz et al., 2015).

    View all citing articles on Scopus
    View full text